Back
Novo Nordisk A/S Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
55
NONOF
Novo Nordisk A/S
Last Price:
$62.50
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atNovo Nordisk A/S Stock Forecast
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 24.4% based on the past 19 years of stock performance.
-
Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
-
Is Novo Nordisk A/S Stock Undervalued?The current Novo Nordisk A/S [NONOF] share price is $62.50. The Score for NONOF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
NONOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 24.4% based on the past 19 years of stock performance.
Novo Nordisk A/S Stock Rating
Buy
55
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S overpriced?
-
Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
94.05
52-Week Low:
42.01
Prediction Charts
Market Cap:
277.7B
Price in USD:
62.50
Volume:
38.5K
Beta:
0.63
Technical Analysis
SMA50:
50.42
SMA100:
53.18
SMA200:
58.86
52-Wk Change:
-24.19%
Stock Predictions
-
Is Novo Nordisk A/S stock public?Yes, Novo Nordisk A/S is a publicly traded company.
-
What is the Novo Nordisk A/S stock quote today?The Novo Nordisk A/S stock price is 62.50 USD today.
-
How to buy Novo Nordisk A/S stock online?You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-29 | 53.12 | 51.50 | 53.12 | 51.00 |
| Dec-30 | 51.50 | 51.20 | 52.81 | 51.05 |
| Dec-31 | 48.63 | 51.05 | 52.00 | 48.63 |
| Jan-2 | 51.25 | 52.74 | 53.05 | 50.60 |
| Jan-5 | 53.50 | 55.77 | 56.39 | 53.24 |
| Jan-6 | 57.05 | 55.60 | 59.00 | 55.10 |
| Jan-7 | 58.64 | 57.32 | 58.64 | 56.32 |
| Jan-8 | 54.59 | 55.01 | 58.00 | 54.59 |
| Jan-9 | 58.98 | 59.01 | 60.99 | 57.68 |
| Jan-12 | 59.00 | 59.45 | 61.69 | 58.00 |
| Jan-13 | 60.00 | 58.78 | 62.47 | 57.74 |
| Jan-14 | 60.25 | 59.00 | 60.73 | 58.01 |
| Jan-15 | 58.25 | 56.17 | 58.25 | 55.85 |
| Jan-16 | 59.75 | 62.50 | 62.54 | 57.50 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.